Literature DB >> 2173592

Catalysis of nitrofuran redox-cycling and superoxide anion production by heart lipoamide dehydrogenase.

C M Sreider1, L Grinblat, A O Stoppani.   

Abstract

Heart lipoamide dehydrogenase (LADH) catalyzed redox-cycling and O2-. production by (5-nitro-2-furfurylidene)amino derivatives using NADH as electron donor. NADH was a much more effective electron donor than NADPH for the nitroreductase activity. O2-. production was demonstrated by cytochrome c reduction, adrenochrome formation and the effect of superoxide dismutase. Under optimum conditions, nitroreductase activity was about 1% of LADH activity. One electron oxygen reduction and NADH oxidation correlated in 2:1 stoichiometry. The nitroreductase kinetics was in accordance with an ordered bi-bi mechanism. Nitrofuran derivatives bearing unsaturated five- or six-membered nitrogen heterocycles were more effective substrates than those bearing other groups, namely nifurtimox, nitrofurazone, nitrofurantoin and 5-nitro-2-furoic acid. Other nitro compounds (chloramphenicol, benznidazole, 2-nitroimidazole and 5-nitroindole) were ineffective. With the triazole, traizine and imidazole nitrofuran derivatives, the nitroreductase pH curve showed a maximum at pH 8.8, different from the pH optimum for the lipoamide reductase and diaphorase activities. Spectroscopic observations demonstrated pH-dependent structural changes in the triazole(I) and triazine derivatives which would affect their behavior as nitroreductase substrates. The nitroreductase activity was inhibited by p-chloromercuribenzoate and enhanced by cadmium and arsenite, whereas the NADH-induced LADH inactivation failed to affect the nitroreductase activity. In the absence of oxygen. LADH catalyzed nitrofuran reduction to products more reduced than the nitroanion, which were not reoxidized by oxygen. The anaerobic nitrofuran reduction was inhibited by cadmium and arsenite. The assayed nitrofuran compounds did not inhibit LADH lipoamide reductase activity, at variance with their action on glutathione reductase (Grinblat et al., Biochem Pharmacol 38: 767-772, 1989).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2173592     DOI: 10.1016/0006-2952(90)90366-s

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  8 in total

1.  Role of cytochrome P450 reductase in nitrofurantoin-induced redox cycling and cytotoxicity.

Authors:  Yun Wang; Joshua P Gray; Vladimir Mishin; Diane E Heck; Debra L Laskin; Jeffrey D Laskin
Journal:  Free Radic Biol Med       Date:  2007-12-23       Impact factor: 7.376

2.  Reversible inactivation of dihydrolipoamide dehydrogenase by mitochondrial hydrogen peroxide.

Authors:  Liang-Jun Yan; Nathalie Sumien; Nopporn Thangthaeng; Michael J Forster
Journal:  Free Radic Res       Date:  2012-12-12

3.  Changes in dihydrolipoamide dehydrogenase expression and activity during postnatal development and aging in the rat brain.

Authors:  Liang-Jun Yan; Nopporn Thangthaeng; Michael J Forster
Journal:  Mech Ageing Dev       Date:  2008-02-06       Impact factor: 5.432

4.  Protein Oxidative Modifications: Beneficial Roles in Disease and Health.

Authors:  Zhiyou Cai; Liang-Jun Yan
Journal:  J Biochem Pharmacol Res       Date:  2013-03

Review 5.  Hyperglycemic Stress and Carbon Stress in Diabetic Glucotoxicity.

Authors:  Xiaoting Luo; Jinzi Wu; Siqun Jing; Liang-Jun Yan
Journal:  Aging Dis       Date:  2016-01-02       Impact factor: 6.745

6.  Reversible inactivation of dihydrolipoamide dehydrogenase by Angeli's salt.

Authors:  Liang-Jun Yan; Li Liu; Michael J Forster
Journal:  Sheng Wu Wu Li Hsueh Bao       Date:  2012-04-20

7.  Mitochondrial Dihydrolipoamide Dehydrogenase is Upregulated in Response to Intermittent Hypoxic Preconditioning.

Authors:  Rongrong Li; Xiaoting Luo; Jinzi Wu; Nopporn Thangthaeng; Marianna E Jung; Siqun Jing; Linya Li; Dorette Z Ellis; Li Liu; Zhengnian Ding; Michael J Forster; Liang-Jun Yan
Journal:  Int J Med Sci       Date:  2015-05-23       Impact factor: 3.738

8.  Chronic Inhibition of Mitochondrial Dihydrolipoamide Dehydrogenase (DLDH) as an Approach to Managing Diabetic Oxidative Stress.

Authors:  Xiaojuan Yang; Jing Song; Liang-Jun Yan
Journal:  Antioxidants (Basel)       Date:  2019-02-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.